4.5 Article

Current Progress Toward a Better Understanding of Drug Disposition Within the Lungs: Summary Proceedings of the First Workshop on Drug Transporters in the Lungs

Journal

JOURNAL OF PHARMACEUTICAL SCIENCES
Volume 106, Issue 9, Pages 2234-2244

Publisher

WILEY
DOI: 10.1016/j.xphs.2017.04.011

Keywords

absorption; computational ADME; efflux pumps; in vitro models; organic cation transporters; P-glycoprotein; peptide transporters; pulmonary delivery/absorption; ABC transporters; organic anion-transporting polypeptide transporters

Funding

  1. International Strategic Collaboration Award from Science Foundation Ireland
  2. Japanese Society for the Study of Xenobiotics
  3. COST Actions [BM1201, MP1404]
  4. Grants-in-Aid for Scientific Research [17K19482, 26293033, 15H04755, 15K08074] Funding Source: KAKEN

Ask authors/readers for more resources

The School of Pharmacy and Pharmaceutical Sciences at Trinity College Dublin hosted the 1st Workshop on Drug Transporters in the Lungs in September 2016 to discuss the impact of transporters on pulmonary drug disposition and their roles as drug targets in lung disease. The workshop brought together about 30 scientists from academia and pharmaceutical industry from Europe and Japan and addressed the primary questions: What do we know today, and what do we need to know tomorrow about transporters in the lung? The 3 themes of the workshop were: (1) techniques to study drug transporter expression and actions in the lungs; (2) drug transporter effects on pulmonary pharmacokinetics-case studies; and (3) transporters as drug targets in lung disease. Some of the conclusions of the workshop were: suitable experimental models that allow studies of transporter effects are available; data from these models convincingly show a contribution of both uptake and efflux transporters on pulmonary drug disposition; the effects of transporters on drug lung PK is now better conceptualized; some transporters are associated with lung diseases. However, more work is needed to establish which of the available models best translate to the clinical situation. (C) 2017 American Pharmacists Association (R). Published by Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available